Krause–Kivlin syndrome
Krause–Kivlin syndrome is a rare genetic disorder characterized by ocular abnormalities and craniofacial anomalies. The syndrome was first described by Krause and Kivlin in 1978, hence the name.
Symptoms and Signs[edit | edit source]
The most common symptoms of Krause–Kivlin syndrome include microphthalmia (abnormally small eyes), microcornea (small cornea), and cataract (clouding of the eye lens). Craniofacial anomalies may include micrognathia (small lower jaw), microcephaly (small head size), and ear deformities. Some individuals may also exhibit intellectual disability and growth retardation.
Causes[edit | edit source]
The exact cause of Krause–Kivlin syndrome is unknown. However, it is believed to be a genetic disorder, possibly inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the defective gene, one from each parent, in order to develop the syndrome.
Diagnosis[edit | edit source]
Diagnosis of Krause–Kivlin syndrome is based on clinical examination and the presence of characteristic symptoms. Genetic testing may be used to confirm the diagnosis and identify the specific gene mutation.
Treatment[edit | edit source]
There is currently no cure for Krause–Kivlin syndrome. Treatment is symptomatic and supportive, and may include surgery to correct ocular and craniofacial abnormalities, as well as special education and therapy for intellectual disability.
Prognosis[edit | edit source]
The prognosis for individuals with Krause–Kivlin syndrome varies depending on the severity of symptoms. With appropriate treatment and support, many individuals can lead fulfilling lives.
See Also[edit | edit source]
- Genetic disorders
- Microphthalmia
- Microcornea
- Cataract
- Micrognathia
- Microcephaly
- Intellectual disability
- Growth retardation
- Autosomal recessive
NIH genetic and rare disease info[edit source]
Krause–Kivlin syndrome is a rare disease.
| Krause–Kivlin syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
